Adaptation of interpersonal psychotherapy to borderline personality disorder: A comparison of combined therapy and single pharmacotherapy

Canadian Journal of Psychiatry

Volumn 55, Issue 2, 2010, Pages 74-81

  Bellino, Silvio ^a   Rinaldi, Camilla ^a   Bogetto, Filippo ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Borderline personality disorder; Combined therapy; Fluoxetine; Interpersonal psychotherapy

Indexed keywords

FLUOXETINE;

ADULT; ARTICLE; BORDERLINE STATE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG INDUCED HEADACHE; DYSPEPSIA; FEMALE; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; HUMAN RELATION; IMPULSIVENESS; INSOMNIA; INTERMETHOD COMPARISON; INTERPERSONAL PSYCHOTHERAPY; LIFE SATISFACTION; MAJOR CLINICAL STUDY; MALE; MENTAL INSTABILITY; MONOTHERAPY; NAUSEA; PATIENT ASSESSMENT; PATIENT COMPLIANCE; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REMISSION; SEMI STRUCTURED INTERVIEW; SOCIAL INTERACTION; TREATMENT DURATION;

EID: 77649203336     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371005500203     Document Type: Article

References (67)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Text revision. Washington (DC): APA; 2000.
2. Bender DS, Dolan RT, Skodol AE, et al. Treatment utilization by patients with borderline personality disorder. Am J Psychiatry. 2001;158(2):295-332.
3. Torgersen S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Arch Gen Psychiatry. 2001;58(6):590 -596.
4. Skodol AE, Gunderson JG, McGlashan TH, et al. Functional impairment in patients with schizotypal, borderline, avoidant or obsessive-compulsive personality disorder. Am J Psychiatry. 2002;159(2):276 -283.
5. American Psychiatric Association. Practice guideline for the treatment of patients with borderline personality disorder. Am J Psychiatry. 2001;158(10 Suppl):1-52.
6. Oldham JM. Guideline watch. Practice guideline for the treatment of patients with borderline personality disorder. Arlington (VA): American Psychiatric Association; 2005.
7. Paris J. Recent advances in the treatment of borderline personality disorder. Can J Psychiatry. 2005;50(8):435- 441.
8. Binks CA, Fenton M, McCArthy L, et al. Pharmacological interventions for people with borderline personality disorder. Cochrane Database Syst Rev. 2006;25(1):CD005653.
9. Binks CA, Fenton M, McCarthy L, et al. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2006;25(1):CD005652.
10. Perry JC, Banon E, Ianni F. Effectiveness of psychotherapy for personality disorder. Am J Psychiatry. 1999;156(9):1312-1321.
11. Clarkin JF, Levy NK, Lenzeweger MF, et al. The Personality Disorders Institute/Borderline Personality Foundation randomized control trial for borderline personality disorder. J Pers Disord. 2004;18(1):52-72.
12. Soler J, Pascual JC, Barrachina J, et al. Double-blind, placebo-controlled study of dialectical behaviour therapy plus olanzapine for borderline personality disorder. Am J Psychiatry. 2005;162(6):1221-1224.
13. Bellino S, Zizza M, Rinaldi C, et al. Combined treatment of major depression in patients with borderline personality disorder: a comparison with pharmacotherapy. Can J Psychiatry. 2006;51(7):453-460.
14. Stevenson J, Meares R. An outcome study of psychotherapy for patients with borderline personality disorder. Am J Psychiatry. 1992;149(3):358-362.
15. Bateman AW, Fonagy P. The effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatry. 1999;156(10):1563-1569.
16. Bateman AW, Fonagy P. Treatment of borderline personality disorder with psychoanalytically oriented partilal hospitalization: an 18-month follow-up. Am J Psychiatry. 2001;158(1):36-42.
17. Kernberg OF, Yeomans FE, Clarkin JF, et al. Transference focused psychotherapy: overview and update. Int J Psychoanal. 2008;89(3):601-620.
18. Linehan MM, Armstrong HE, Suarez A, et al. Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry. 1991;48(12):1060-1064.
19. Linehan MM, Schmidt H, Dimeff LA, et al. Dialectical behaviour therapy for patients with borderline personality disorder and drug-dependence. Am J Addict. 1999;8(4):279-292.
20. Koons C, Robins CJ, Tweed JL, et al. Efficacy of dialectical behaviour therapy in women veterans with borderline personality disorder. Behav Res Ther. 2001;32:371-390.
21. Verheul R, van den Bosch LMC, Koeter MW, et al. Dialectical behaviour therapy for women with borderline personality disorder. Br J Psychiatry. 2003;182:135-140.
22. Linehan MM, Comtois KA, Murray AM, et al. Two-year randomized controlled trial and follow-up of dialectical behaviour therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry. 2007;64(12):1401. Erratum.
23. Beck AT, Freeman A. Cognitive therapy of personality disorder. New York (NY): Guilford Press; 2003.
24. Brown GK, Newman CF, Charlesworth SE, et al. An open clinical trial of cognitive therapy for borderline personality disorder. J Pers Disord. 2004;18(3):257-271.
25. Wenzel A, Chapman JE, Newman CF, et al. Hypothesized mechanisms of change in cognitive therapy for borderline personality disorder. J Clin Psychol. 2006;62(4):503-516.
26. Klerman GL, Weissman MM, Rounsaville BJ, et al. Interpersonal psychotherapy of depression. New York (NY): Basic Books; 1984.
27. Markowitz JC. Interpersonal psychotherapy for dystymic disorder. Washington (DC): American Psychiatric Press; 1998.
28. Lipsitz JD, Fyer AJ, Markowitz JC, et al. An open trial of interpersonal psychotherapy for social phobia. Am J Psychiatry. 1999;156(11):1814-1816.
29. Frank E, Swartz HA, Kupfer DJ. Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder. Biol Psychiatry. 2000;48(6):593-604.
30. Agras WS, Walsh BT, Fairburn CG, et al. A multicenter comparison of cognitive-behavioral therapy and interpersonal psychotherapy for bulimia nervosa. Arch Gen Psychiatry. 2000;57(5):459-466.
31. Weissman MM, Markowitz JC, Klerman GL. Comprehensive guide to interpersonal psychotherapy. New York (NY): Basic Books; 2000.
32. Browne G, Steiner M, Roberts J, et al. Sertraline and/or interpersonal psychotherapy for patients with dystimic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and cost. J Affect Disord. 2002;68(2-3):317-330.
33. De Mello MF, De Jesus MJ, Bacaltchuk J, et al. A systematic review of research findings on the efficacy interpersonal therapy for depressive disorders. Eur Arch Psychiatry Clin Neurosci. 2005;255(2):75-82.
34. Markowitz JC. Interpersonal therapy of personality disorders. In: Oldham JM, Skodol AE, Bender BS, editors. Textbook of personality disorders. Washington (DC): American Psychiatric Press; 2005. p 321-334.
35. Markowitz JC, Skodol AE, Bleiberg K. Interpersonal psychotherapy for borderline personality disorder: possible mechanisms of change. J Clin Psychol. 2006;62(4):431-444.
36. Bellino S, Zizza M, Rinaldi C, et al. Combined therapy of major depression with concomitant borderline personality disorder: comparison of interpersonal and cognitive psychotherapy. Can J Psychiatry. 2007;52(11):718-725.
37. Angus L, Gillies LA. Counseling the borderline client: an interpersonal approach. Can J Couns. 1994;28:69-82.
38. Soloff PH. Algorithm for pharmachological treatment of personality dimensions: symptom-specific treatments for cognitive-perceptual, affective and impulsive-behaviour dysregulations. Bull Menninger Clin. 1998;62(2):195-214.
39. Norden MJ. Fluoxetine in borderline personality disorder. Prog Neuropsychopharmacol Biol Psychiatry. 1989;13(6):885-893.
40. Coccaro EF, Kavoussi RJ. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry. 1997;54:1081-1088.
41. Salzman C, Wolfson AN, Schatzberg A, et al. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol. 1995;15:23-29.
42. Simpson EB, Yen S, Costello E, et al. Combined dialectical behavior therapy and fluoxetine in the treatment of borderline personality disorder. J Clin Psychiatry. 2004;65(3):375-385.
43. Zanarini MC, Frankenburg FR, Parachini EA. A preliminary randomized trial of fluoxetine, olanzapine, and olanzapine-fluoxetine combination in women with borderline personality disorder. J Clin Psychiatry. 2004;65(7):903-907.
44. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). Washington (DC): American Psychiatric Press; 1997.
45. First MB, Gibbon M, Spitzer RL, et al. Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II). Washington (DC): American Psychiatric Press; 1997.
46. Guy W. ECDEU assessment manual for psychopharmacology. US Department of Health, Education, and Welfare publication (ADM) 76-338. Rockville (MD): National Institute of Mental Health; 1976.
47. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
48. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychology. 1959;32:50-55.
49. Goldman HH, Skodol AE, Lave TR. Revising Axis V for DSM-IV: a review of measures of social functioning. Am J Psychiatry. 1992;149(9):1148-1156.
50. Majani G, Callegari S. SAT-P Satisfaction Profile. Soddisfazione soggettiva e qualità della vita. Trento (IT): Erickson; 1998.
51. Arntz A, Van den Hoorn M, Cornelis J, et al. Reliability and validity of the borderline personality disorder severity index. J Pers Disord. 2003;17(1):45-59.
52. Henkel V, Seemüller F, Obermeier M, et al. Does early improvement triggered by antidepressants predict response/remission?-analysis of data from a naturalistic study on a large sample of inpatients with major depression. J Affect Disord. 2008 Nov 21; [Epub ahead of print].
53. Mazza M, Squillacioti MR, Pecora RD, et al. Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial. Expert Opin Pharmacother. 2008;9(18):3145-3149.
54. Seguì J, López-Muñoz F, Alamo C, et al. Effects of adjunctive reboxetine in patients with duloxetine-resistant depression: a 12-week prospective study. J Psychopharmacol. 2009 Mar 12; [Epub ahead of print].
55. Gunderson JG. Disturbed relationships as a phenotype for borderline personality disorder. Am J Psychiatry. 2007;164(11):1637-1639.
56. Frank J. Therapeutic factors in psychotherapy. Am J Psychother. 1971;25:350-361.
57. Klerman GL, Dimascio A, Weissman M, et al. Treatment of depression by drugs and psychotherapy. Am J Psychiatry. 1974;131(2):186-191.
58. Rosselló J, Bernal G. The efficacy of cognitive-behavioral and interpersonal treatments for depression in Puerto Rican adolescents. J Consult Clin Psychol. 1999;67(5):734-745.
59. Mufson L, Weissman MM, Moreau D, et al. Efficacy of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry. 1999;56(6):573-579.
60. Markowitz JC. Interpersonal psychotherapy for chronic depression. J Clin Psycol. 2003;59(8):847-858.
61. Parker G, Parker I, Brotchie H, et al. Interpersonal psychotherapy for depression? The need to define its ecological niche. J Affect Disord. 2006;95(1-3):1-11.
62. Clarkin JF, Hull JW, Hurt SW. Factor structure of borderline personality disorder criteria. J Pers Disord. 1993;7:137-143.
63. Sanislow CA, Grilo CM, McGlashan TH. Factor analysis of the DSM-III-R borderline personality criteria in psychiatric inpatients. Am J Psychiatry. 2000;157(10):1629-1633.
64. Sanislow CA, Grilo CM, Morey CL, et al. Confirmatory factor analysis of DSM-IV criteria for borderline personality disorder: findings from the Collaborative Longitudinal Personality Disorders Study. Am J Psychiatry. 2002;159(2):284-290.
65. Skodol AE, Gunderson JG, Pfohl B, et al. The borderline diagnosis I: psychopathology, comorbidity, and personality structure. Biol Psychiatry. 2002;51(12):936-950.
66. Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale-preliminary report. Psychopharmacol Bull. 1973;9(1):13-28.
67. Robins CJ, Chapman AL. Dialectical behaviour therapy: current status, recent developments, and future directions. J Pers Disord. 2004;18(1):73-89.